Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 09, 2018

SELL
$8.55 - $13.76 $1.7 Million - $2.73 Million
-198,558 Closed
0 $0
Q1 2018

May 02, 2018

BUY
$8.99 - $14.95 $1.79 Million - $2.97 Million
198,558 New
198,558 $1.83 Million

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $365M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Texas Treasury Safekeeping Trust CO Portfolio

Follow Texas Treasury Safekeeping Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Treasury Safekeeping Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Texas Treasury Safekeeping Trust CO with notifications on news.